Ulnar Skeletal Dysplasia (Ellis‑van Creveld)
Overview
Ulnar skeletal dysplasia, more commonly referred to as Ellis‑van Creveld syndrome (EVC), is a rare autosomal‑recessive genetic disorder that affects bone growth, teeth, heart development, and sometimes the kidneys and respiratory tract. The hallmark features are short stature, short (or absent) limbs—particularly the ulna and fibula—polydactyly (extra fingers/toes), and characteristic facial features. Because the condition involves multiple organ systems, patients may need coordinated care from genetics, orthopedics, cardiology, dentistry, and pulmonology specialists.
Who it affects: Both males and females are equally affected. The disorder is most common in communities with a high rate of consanguineous (related) marriages, such as the Amish population in North America and certain Bedouin groups in the Middle East. Worldwide prevalence has been estimated at 1 in 60,000 to 1 in 200,000 live births, but exact numbers are hard to determine due to under‑diagnosis in low‑resource settings.1
Symptoms
The clinical picture varies widely, even among members of the same family. Below is a comprehensive list of the most frequently reported manifestations, grouped by system.
Skeletal & Limb Anomalies
- Short stature: Adult height typically 120–130 cm (4–4.3 ft).
- Short forearms and lower legs: Disproportionately shortened ulna and fibula; radius and tibia may appear relatively normal.
- Absent or hypoplastic ulna (or fibula): May lead to wrist instability or ankle malalignment.
- Polydactyly: Usually post‑axial (extra digit on the ulnar side of the hand or lateral side of the foot). The extra digit is often rudimentary but can be functional.
- Broad ribs and narrow chest cavity: Contribute to restrictive lung disease.
- Joint contractures: Limited range of motion at elbows, knees, or ankles.
Facial & Oral Features
- Facial dysmorphism: Small, widely spaced eyes; short, flat nasal bridge; prominent forehead; and a “trigono‑cupid” (square‑shaped) mouth.
- Dental anomalies: Enamel hypoplasia, irregular tooth eruption, and a higher risk of cavities.
Cardiovascular
- Congenital heart defects: Up to 60 % of patients have atrial septal defects (ASD) or ventricular septal defects (VSD). Some present with more complex lesions such as double‑outlet right ventricle.
Respiratory
- Restrictive lung disease: Stiff chest wall can cause reduced vital capacity, especially in infants.
- Recurrent respiratory infections: Due to limited thoracic expansion.
Renal & Genitourinary
- Kidney anomalies (e.g., hypoplastic kidneys, urinary tract malformations) occur in ~20 % of cases.
Other Findings
- Hepatic fibrosis (rare).
- Hearing loss due to middle‑ear abnormalities.
Causes and Risk Factors
Ellis‑van Creveld syndrome is caused by pathogenic variants in either the EVC or EVC2 genes, which lie next to each other on chromosome 4p16. These genes encode proteins that are part of the Hedgehog signaling pathway—a critical regulator of embryonic development, especially of bone and cartilage.2 Loss‑of‑function mutations disrupt normal limb patterning and organogenesis.
Because the inheritance pattern is autosomal recessive, a child must receive a mutated copy of the gene from each parent. Consequently, the main risk factors are:
- Both parents are carriers of a pathogenic variant.
- Consanguineous marriage (first‑cousin or closer relationships) increases carrier pairing.
- Family history of EVC or other skeletal dysplasias.
The carrier frequency in the general population is low (≈1 in 300–500), but it rises dramatically in isolated communities with limited genetic diversity (e.g., Amish carrier rate ≈1 in 30).3
Diagnosis
Diagnosis is primarily clinical, supported by imaging and molecular testing.
Clinical Evaluation
- Detailed physical exam noting limb proportions, polydactyly, chest shape, facial features, and cardiac murmurs.
- Growth charts to document short stature and growth velocity.
Imaging Studies
- Radiographs (X‑rays): Show shortened ulna/fibula, broadened ribs, and irregular epiphyses.
- Echocardiography: Detects ASD, VSD, or other structural heart disease.
- Chest CT or MRI: Assesses severity of thoracic restriction if respiratory symptoms are present.
- Renal ultrasound: Screens for kidney anomalies.
Genetic Testing
A definitive diagnosis is achieved by identifying pathogenic variants in EVC or EVC2 through:
- Targeted gene panels for skeletal dysplasia.
- Whole‑exome sequencing (WES) when the phenotype is atypical.
Carrier testing is recommended for siblings and future parents, and pre‑implantation genetic diagnosis (PGD) can be considered for couples undergoing in‑vitro fertilization.
Other Laboratory Tests
- Basic metabolic panel to evaluate renal function.
- Pulmonary function tests (PFTs) in school‑age children and adolescents.
- Dental X‑rays for early detection of enamel defects.
Treatment Options
There is no cure for Ellis‑van Creveld syndrome; management focuses on correcting structural problems, preventing complications, and maximizing functional independence.
Medical Management
- Cardiac care: Small ASDs/VSDs may close spontaneously; larger defects often require surgical closure or catheter‑based interventions. Lifelong cardiology follow‑up is essential.
- Respiratory support: Physiotherapy, incentive spirometry, and, in severe cases, non‑invasive ventilation.
- Renal monitoring: Early referral to nephrology if ultrasound shows abnormalities; manage hypertension or proteinuria per KDIGO guidelines.
- Dental hygiene: Fluoride varnish, regular dental visits, and sealants to prevent cavities.
Surgical Interventions
- Limb‑lengthening (Ilizarov or external fixator techniques): May improve functional reach and gait, typically performed in late childhood.
- Polydactyly excision: Cosmetic and functional removal of extra digits, usually before school age.
- Thoracic expansion surgery: Rare, reserved for severe restrictive lung disease.
- Orthopedic corrections: Tendon releases, osteotomies, or ankle/knee arthrodesis to address contractures.
Therapies & Lifestyle Adjustments
- Physical therapy: Stretching, strengthening, and gait training to maintain joint range.
- Occupational therapy: Adaptive devices (e.g., modified utensils, reachers) for daily living.
- Respiratory therapy: Airway clearance techniques and regular aerobic exercise within tolerance.
- Nutrition: Adequate caloric intake to support growth; supplementation of calcium and vitamin D if indicated.
Pharmacologic Options
There are no disease‑modifying drugs for EVC. Medications are used symptomatically:
- Beta‑blockers or ACE inhibitors for heart failure secondary to large shunts.
- Bronchodilators for airway hyperreactivity.
- Analgesics (acetaminophen or NSAIDs) for musculoskeletal pain.
Living with Ulnar Skeletal Dysplasia (Ellis‑van Creveld)
While the condition presents lifelong challenges, many individuals lead active, fulfilling lives with appropriate support.
Practical Daily‑Management Tips
- Assess home safety: Install grab bars, non‑slip mats, and lower countertops to compensate for short stature.
- Use adaptive equipment: Reach‑extending tools, button hooks, and weighted utensils can reduce frustration.
- Stay physically active: Low‑impact activities (swimming, cycling, seated aerobics) improve lung capacity and joint health.
- Regular monitoring schedule:
- Cardiology: every 6–12 months or sooner if symptoms change.
- Orthopedics: annually, or after growth spurts.
- Dentistry: every 6 months.
- Education & Employment: Disclosure of physical limitations can help secure reasonable accommodations (e.g., adjustable workstations).
- Psychosocial support: Counseling or peer‑support groups (e.g., Rare Disease Day communities) address body‑image concerns and social stigma.
Prevention
Because EVC is genetic, primary prevention focuses on reducing the chance of having an affected child:
- Carrier screening: Offered to individuals from high‑risk communities or with a family history.
- Genetic counseling: Discuss recurrence risk (25 % per pregnancy) and reproductive options (PGD, donor gametes, adoption).
- Prenatal testing: Chorionic villus sampling or amniocentesis with targeted EVC/EVC2 analysis for at‑risk pregnancies.
Beyond genetics, there are no lifestyle measures that can prevent the disorder.
Complications
If untreated or poorly managed, the following complications may arise:
- Heart failure: Large unrepaired ASDs/VSDs lead to pulmonary hypertension and reduced cardiac output.
- Severe respiratory restriction: Chronic hypoxia, exercise intolerance, and increased infection risk.
- Progressive joint deformities: Resulting in chronic pain, reduced mobility, and increased fall risk.
- Dental decay: Enamel defects can lead to early tooth loss, affecting nutrition.
- Renal insufficiency: Structural anomalies may predispose to chronic kidney disease.
- Psychological impact: Social isolation and low self‑esteem are more common in adolescents.
When to Seek Emergency Care
- Sudden, severe chest pain or pressure, especially with shortness of breath.
- Rapid heart rate (>130 bpm) accompanied by dizziness, fainting, or bluish skin (cyanosis).
- Acute worsening of breathing difficulty, wheezing, or inability to speak full sentences.
- Sudden swelling of the abdomen or legs suggesting heart failure.
- High fever (>38.5 °C/101 °F) with a rapid increase in respiratory symptoms – possible pneumonia.
- Severe injury to the limbs (suspected fracture or dislocation) causing uncontrollable pain.
Sources:
- Mayo Clinic. “Ellis‑van Creveld syndrome.” Accessed May 2024. https://www.mayoclinic.org
- National Institutes of Health, Genetics Home Reference. “EVC gene.” 2023. https://ghr.nlm.nih.gov
- World Health Organization. “Genetic disorders in isolated populations.” WHO Press, 2022.
- Cleveland Clinic. “Congenital heart disease in Ellis‑van Creveld syndrome.” 2024. https://my.clevelandclinic.org
- American Heart Association. “Guidelines for the Management of Adults With Congenital Heart Disease.” 2023.
- American Academy of Pediatrics. “Skeletal Dysplasias: Diagnosis and Management.” 2022.